Delineate is a data extraction and analysis platform that leverages AI to process research literature and patents for the biopharmaceutical industry. Delineate helps pharmaceutical companies extract meaningful, structured datasets from a vast volume of scientific publications, including complex data embedded in figures and plots.
Delineate addresses a critical challenge in drug development: despite significant investment, 90% of drug candidates fail, often due to incomplete or inaccessible research data. By automating the extraction and aggregation of data from research papers and patents, Delineate aims to improve evidence-based decision-making in pharmaceutical R&D.
The Technology That Powers Delineate
Delineate’s platform is built on custom large language models (LLMs) and advanced computer vision algorithms, specifically tailored for parsing complex scientific documents. This combination allows Delineate to:
- Extract data not only from text but also from figures, plots, and tables commonly found in research literature.
- Scale processing to handle 15x more studies than industry standard approaches.
- Deliver rigorously quality-controlled datasets much faster, reducing months of manual review to just weeks.
The company’s AI-driven workflow is paired with strict quality control protocols, ensuring high accuracy and reliability of the extracted data—an essential requirement in regulated biopharma environments.
Who Uses Delineate?
Delineate primarily serves pharmaceutical and biotechnology companies that rely on large-scale literature review and data analysis to inform drug development and clinical strategy. Notable customers include major industry players such as Sanofi and Roche, who have used Delineate’s datasets for some of the largest aggregated research studies in the sector.
The platform is particularly valuable for R&D, competitive intelligence, and teams seeking to accelerate evidence synthesis from the ever-growing body of biomedical literature and patents.
Competitive Landscape: Who Are Delineate’s Competitors?
Delineate operates in the AI-powered scientific literature extraction and analysis space. Key competitors and alternative solutions include:
- IQVIA: Offers AI-assisted scientific literature review services to accelerate insights from large volumes of publications.
- Causaly: Provides AI-driven tools for extracting scientific knowledge from biomedical literature, focusing on biomarker identification and drug discovery insights.
While established players like IQVIA have broad healthcare data capabilities, Delineate differentiates itself through its focus on extracting complex data from figures and its custom models for pharmaceutical R&D use cases.
Use PromptLoop to Uncover Company Data
Looking for more company insights like this? PromptLoop helps you go deeper, providing unique data points and analysis on companies like Delineate and many others. Automate your research and find the information that matters most. Discover how PromptLoop can accelerate your market intelligence. Get A Free Demo to learn more.